Research Alert: CFRA Raises Opinion To Buy From Hold On Shares Of Royal Caribbean Cruises Ltd.

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print

04:00 PM EDT, 03/19/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We upgrade our opinion to Buy from Hold based on our view of an attractive valuation at current levels. Our 12-month price target is $297 (unchanged), based on a 2025 EV/EBITDA multiple of 15x, a premium to historic averages, justified by sales growth and earnings quality. Our EPS estimates are unchanged at $14.62 in 2025 and $16.18 in 2026. In our view, recent weakness in shares reflects overblown negative sentiment around policy uncertainty and the direction of consumer spending. We think investors undervalue RCL's leadership on hardware and global itineraries, which are helping fuel strong occupancy rates. We see further margin expansion opportunities ahead as net yields grow ahead of cruise costs. Strong booking trends suggest travel and leisure trends are healthy heading into Q1 2025, giving us a higher degree of certainty that RCL is on the right path to achieve a 20% EPS CAGR from 2025 to 2027.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

© 1999-2025 Midnight Trader, Inc. All rights reserved.

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print
close
Please enter a valid e-mail address
Please enter a valid e-mail address
Important legal information about the e-mail you will be sending. By using this service, you agree to input your real e-mail address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an e-mail. All information you provide will be used by Fidelity solely for the purpose of sending the e-mail on your behalf.The subject line of the e-mail you send will be "Fidelity.com: "

Your e-mail has been sent.
close

Your e-mail has been sent.